Tryeyes and Icom have reached a final agreement on a strategic capital and business alliance that converts LIMNO into a joint venture. Tryeyes will transfer 49% of LIMNO’s shares to Icom, and LIMNO will be jointly operated under a 51:49 ownership structure. Additional capital measures, including further transfers\/allocations, will be implemented. Governance structures, pre-approval items, and decision-making processes for key matters are defined.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6820","jir_company_name":"Icom Incorporated","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/6820-20261030-01.pdf","jir_short_summary":"Tryeyes and Icom have reached a final agreement on a strategic capital and business alliance that converts LIMNO into a joint venture. Tryeyes will transfer 49% of LIMNO's shares to Icom, and LIMNO will be jointly operated under a 51:49 ownership structure. Additional capital measures, including further transfers\/allocations, will be implemented. Governance structures, pre-approval items, and decision-making processes for key matters are defined.","jir_summary":"### Overview of the Alliance\nThis transaction is a strategic capital and business alliance involving the conversion of LIMNO Co., Ltd. into a joint venture. Tryeyes will transfer 49% of the LIMNO shares it holds to Icom Incorporated, and LIMNO will be jointly operated with Tryeyes holding 51% and Icom holding 49%. The capital relationship will be strengthened through transfers and deliveries of shares utilizing third-party allotments, and mutual share transfers will be subject to transfer restrictions during the contract period.\n\n### Schedule and Impact\nThe planned schedule is: October 1, 2026 as the share transfer date for LIMNO, and November 16, 2026 as the execution date of the LIMNO share transfer and the official contract and start date of the alliance. Tryeyes and Icom will seek to strengthen LIMNO's manufacturing base, expand sales channels, and reinforce the supply chain, aiming to acquire new ODM\/OEM projects for drone-related components and beauty appliances.","jir_financial_highlights":"Ownership ratio after transfer of LIMNO shares: Tryeyes 51% \u00b7 Icom 49% (Initial: Tryeyes 100% \u2192 After transfer: 51%\/49%)\nLIMNO capital: 61,000,000 yen (Unknown)","jir_category":"","jir_hashtags":"#LIMNO, #StrategicCapitalandBusinessAlliance, #JointVenture","jir_key_figures":"Ownership ratio after LIMNO share transfer: 51%\/49%\nNumber of shares transferred: 58,800 shares (49%)\nTransfer price: 360,000,000 yen","jir_meta_title":"Tryeyes \/ Icom Incorporated Finalize Strategic Capital and Business Alliance Converting LIMNO into a Joint Venture | October 2026","jir_meta_description":"Tryeyes and Icom Incorporated have finalized a strategic capital and business alliance centered on converting LIMNO into a joint venture. Ownership will be 51:49, with details on future share allocations, governance, and pre-approval requirements clarified.","jir_og_title":"Tryeyes & Icom Incorporated Finalize Joint Venture Conversion of LIMNO and Strategic Capital Alliance","jir_og_description":"Announcement of an alliance involving conversion of LIMNO into a joint venture. Ownership after share transfer will be 51:49, with the schedule and business development direction outlined.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17550,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-138983","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n